Insider filing · CRNX
Richard Scott Struthers
President & CEO
profile →
Crinetics Pharmaceuticals, Inc.
CRNX · Healthcare · 30 filings in 24 months
ticker →
Richard Scott Struthers sold $563K of Crinetics Pharmaceuticals (CRNX)
Executed Mar 19 2025, disclosed Mar 21 2025, 2 days later.
Value, as filed
$563K
16,463 sh × $34.17
Executed
Mar 19 2025
the trade date, as filed
Disclosed
Mar 21 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RSRichard Scott Struthers (President & CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $822K of CRNX (21,981 sh across 2 lots, as filed), executed Mar 16.
The name
CRNXHealthcare · Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of n…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Richard Scott Struthers in CRNX
CRNXSALE
Crinetics Pharmaceuticals, Inc.
$822K21,981 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. $180K
4,000 sh × $45.00
Exec Sep 26 2025
Filed Sep 30 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. $576K
10,000 sh × $57.57
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET